Your browser is no longer supported. Please, upgrade your browser.
GWPH GW Pharmaceuticals plc daily Stock Chart
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-9.27 Insider Own0.04% Shs Outstand27.30M Perf Week-4.25%
Market Cap3.26B Forward P/E25.49 EPS next Y4.69 Insider Trans0.00% Shs Float1.68M Perf Month-9.57%
Income-244.60M PEG- EPS next Q-2.47 Inst Own79.80% Short Float- Perf Quarter-15.34%
Sales16.20M P/S201.43 EPS this Y47.40% Inst Trans0.95% Short Ratio- Perf Half Y-18.29%
Book/sh18.11 P/B6.60 EPS next Y184.50% ROA-46.10% Target Price175.82 Perf Year-3.59%
Cash/sh16.24 P/C7.36 EPS next 5Y- ROE-52.70% 52W Range105.12 - 179.65 Perf YTD-9.45%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-33.47% Beta2.14
Dividend %- Quick Ratio11.20 Sales past 5Y-14.10% Gross Margin67.00% 52W Low13.71% ATR5.98
Employees586 Current Ratio11.30 Sales Q/Q50.00% Oper. Margin- RSI (14)37.67 Volatility3.76% 4.61%
OptionableYes Debt/Eq0.01 EPS Q/Q-63.70% Profit Margin- Rel Volume0.51 Prev Close120.86
ShortableYes LT Debt/Eq0.01 EarningsNov 27 AMC Payout- Avg Volume639.78K Price119.53
Recom2.00 SMA20-4.26% SMA50-11.98% SMA200-13.81% Volume324,418 Change-1.10%
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Sep-26-16Reiterated Cantor Fitzgerald Buy $165 → $182
Aug-26-16Upgrade Numis Sell → Hold
Aug-09-16Reiterated Cantor Fitzgerald Buy $181 → $165
Jun-03-16Initiated Cantor Fitzgerald Buy $181
Mar-03-16Initiated Numis Sell
Dec-14-18 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Moves -1.1%: What You Should Know Zacks
Dec-13-18 08:40AM  4 Marijuana Stocks To Watch On Thursday ACCESSWIRE
Dec-12-18 11:17AM  Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November Motley Fool
09:30AM  Cannabis Winners in 2018 Poised for a Bigger 2019 ACCESSWIRE
08:30AM  Electricity Usage By Cannabis Growers Ballooning ACCESSWIRE
Dec-11-18 09:45AM  Marijuana Stocks Gain Attention As Cannabis Industry Jobs Grow ACCESSWIRE
Dec-09-18 09:06AM  2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb Motley Fool
09:00AM  Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals Motley Fool
Dec-07-18 12:30PM  What the Future Holds for Canopy Growth Stock InvestorPlace
Dec-05-18 08:21AM  These 17 Pot Stocks Were Throttled in November Motley Fool
Dec-04-18 05:45PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
12:20PM  Bank Of America Bullish On GW Pharma, Expects Growth In Epidiolex Sales Benzinga
09:00AM  Marijuana Stocks Get Boost On Deal News ACCESSWIRE
Dec-03-18 03:01PM  Cantor Fitzgerald Lowers GW Pharmaceuticals Price Target Benzinga
12:16PM  How dangerous are marijuana stocks? Even a company with notable achievements has plunged MarketWatch
10:45AM  The Marijuana Stocks Making Waves This Week ACCESSWIRE
Dec-01-18 09:06AM  The 12 Largest Marijuana Stocks Motley Fool
08:21AM  You'll Never Guess Which Asian Country Just Legalized Medical Marijuana Motley Fool
Nov-30-18 10:23AM  Serious Questions Surround CV Sciences Stock InvestorPlace
Nov-29-18 10:27AM  Cannabis Cash From High-Less Hemp Beckons to Ailing U.S. Farmers Bloomberg
07:30AM  Investor Expectations to Drive Momentum within ANSYS, Nordic American Tankers, Woodward, GW Pharmaceuticals, CareTrust REIT, and TOCAGEN INC Discovering Underlying Factors of Influence GlobeNewswire
Nov-28-18 03:11PM  Cantor Fitzgerald Bullish On GW Pharmaceuticals, Sees 75% Upside Potential Benzinga
08:21AM  3 Marijuana Stocks to Avoid Like the Plague in December Motley Fool
07:46AM  The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings Benzinga
Nov-27-18 11:32PM  GW Pharmaceuticals Plc (GWPH) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:48PM  GW Pharmaceuticals (GWPH) Stock Is Sliding on Q4 Revenue Miss InvestorPlace
05:05PM  GW Pharma Slides After Cannabis-Based Biotech Lags Sales Views Investor's Business Daily
04:47PM  GW Pharma Beats Q4 EPS Estimates, Misses On Revenue Benzinga
04:42PM  GW Pharmaceuticals stock ticks down after revenue miss MarketWatch
04:00PM  GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress GlobeNewswire
11:15AM  Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It? Motley Fool
09:44AM  Company News For Nov 27, 2018 Zacks
07:26AM  GW Pharmaceuticals Q4 Earnings Preview Benzinga
06:30AM  TLRY and NMTC: Two Takes On Treating Brain Disorders That Could Be Worth Billions ACCESSWIRE
Nov-26-18 12:46PM  Marijuana Stocks: GW Phamaceuticals Stock Surges on Late-Stage Study Success InvestorPlace
10:40AM  Healthcare Stocks Rally Has Investors Looking At These 4 Companies ACCESSWIRE
09:53AM  Additional Late-Stage Study Confirms Efficacy, Safety Of GW Pharma's Epidiolex Benzinga
07:29AM  UPDATE: GW Pharma shares up 2.4% premarket on news of positive trial for cannabis-based drug MarketWatch
07:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Sage Therapeutics ACCESSWIRE
07:00AM  GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome GlobeNewswire
02:00AM  FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer CNW Group
Nov-24-18 09:06AM  Forget THC! Cannabidiol (CBD) Is the Marijuana Industry's Moneymaker Motley Fool
07:33AM  Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals Motley Fool
Nov-23-18 04:54PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
10:11AM  What's in Store for GW Pharma (GWPH) This Earnings Season? Zacks
Nov-19-18 04:05PM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting GlobeNewswire -5.22%
09:45AM  4 Marijuana Stocks Expanding Across North America ACCESSWIRE
Nov-16-18 02:44PM  4 Lit Marijuana Stocks to Buy Kiplinger
Nov-15-18 03:00PM  What Is CBD And How Can Investors Take Advantage Of It? Benzinga
Nov-14-18 12:43PM  4 Reasons Why Leerink Is Bullish On GW Pharma Benzinga
07:31AM  GW Pharma initiated at Leerink with 'outperform' rating MarketWatch
Nov-13-18 11:30AM  Election Night Cannabis Approvals Could Benefit These Companies ACCESSWIRE
Nov-10-18 02:51PM  Why GW Pharmaceuticals Stock Dropped 20% in October Motley Fool
10:30AM  Why people love CBD the cannabis product that won't get you high CNBC
Nov-08-18 10:46AM  Cannabis markets are expected to grow by 700 percent by 2020: RPT Yahoo Finance Video
Nov-07-18 09:02AM  Top Marijuana Stocks to Watch Investopedia +5.65%
07:00AM  Marijuana Stocks Are Being Bought Up by Big Banks
Nov-06-18 03:20PM  9 High-Risk Stocks to Buy for Massive Rewards InvestorPlace
12:18PM  3 Smokin Hot Marijuana Stocks to Trade for the Next High InvestorPlace
10:00AM  CBD Stocks on The Rebound ACCESSWIRE
07:00AM  GW Pharmaceuticals to Report Fourth Quarter and Year-End Financial Results and Host Conference Call on 27 November, 2018 GlobeNewswire
Nov-05-18 01:48PM  Weed is on the ballot in these 5 states Yahoo Finance Video
Nov-04-18 09:36AM  The First Cannabis-Derived Drug Is Now on Pharmacy Shelves Motley Fool
Nov-02-18 06:45PM  GW Pharmaceuticals PLC (GWPH) Dips More Than Broader Markets: What You Should Know Zacks
03:13PM  Experts Weigh In On Medical Cannabis Products Now Available In The UK Benzinga
02:11PM  Cannabis investor: 'It's not just about Canada. It's not just about the US' Yahoo Finance
12:15PM  A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies Benzinga
10:15AM  Friday's Top Trending Marijuana Stocks ACCESSWIRE
08:06AM  GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined
Nov-01-18 07:24PM  'Important to distinguish between what's medicine and wha... CNBC Videos +7.10%
06:51PM  GW Pharma CEO after new drug launch: It's 'important to d... CNBC Videos
06:31PM  GW Pharma CEO: It's 'important to distinguish between what's medicine and what's not' in cannabis CNBC
10:00AM  Oversold CBD Stocks ACCESSWIRE
06:45AM  EPIDIOLEX® (cannabidiol) Oral Solution the First FDA-approved Plant-derived Cannabinoid Medicine Now Available by Prescription in the U.S. GlobeNewswire
Oct-30-18 07:51AM  These 6 Pot Stocks Account for Virtually All Marijuana Short Interest Motley Fool
Oct-27-18 08:37PM  What Are the Risks of Investing in Marijuana Stocks? Motley Fool
Oct-26-18 02:00PM  Short Sellers Are Making Huge Profits In Cannabis Stocks Benzinga
Oct-25-18 01:17PM  Marijuana Stocks: Valuations -- and Why Investors Are Paying Massive Premiums Motley Fool
12:01PM  What Are the Side Effects of Marijuana? Experts Explain in 2018
06:30AM  6 Marijuana Companies Make Up 90% of Short Interest in the Sector Investopedia
Oct-24-18 11:30AM  This CBD Stock Soared Over 2000% ACCESSWIRE
09:21AM  These 2 Marijuana Stocks Are Now Legally Exporting Cannabis to the U.S. Motley Fool
07:19AM  The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands Zacks
Oct-23-18 10:09AM  Medical Cannabis Stocks Vs. Recreational Cannabis Stocks: Which Ones Should You Invest In? Investopedia
08:32AM  Marijuana Stocks Plummet to Record Low: What's Next? Zacks
Oct-21-18 11:46AM  Better Buy: GW Pharmaceuticals PLC vs. 22nd Century Group Inc. Motley Fool
Oct-20-18 11:20AM  Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and more MarketWatch
Oct-19-18 02:00PM  9 Marijuana Stocks to Play the Pot Craze InvestorPlace
08:10AM  Investor Expectations to Drive Momentum within Motorola Solutions, Shire plc, Bitauto, GRIDSUM HOLDING, GW Pharmaceuticals, and Actinium Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Oct-18-18 11:10AM  Stocks in Position to Beat the Failing Market ACCESSWIRE
Oct-17-18 01:07PM  The '420 Investor' Talks Canada's Legalization, Calls Cannabis Stocks A Crowded Trade Right Now Benzinga
12:43PM  What Stocks are on the Marijuana Index? Investopedia
Oct-16-18 03:47PM  The Most Unique Pot Stocks Investopedia
11:15AM  Marijuana Stocks to Watch in October -- and Into 2019 Motley Fool
Oct-15-18 06:03PM  Key event in the next month could take U.S. one step clos... CNBC Videos
03:30PM  5 Marijuana Stocks to Watch InvestorPlace
10:30AM  Why This Company is Set for a Major Breakout ACCESSWIRE
08:21AM  5 of the Most Unique Marijuana Stocks Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Aerie Pharmaceuticals ACCESSWIRE
Oct-12-18 12:45PM  How to Invest in Marijuana Stocks Motley Fool
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates, which are in Phase I and II clinical development for the treatment of glioma, neonatal hypoxic-ischemic encephalopathy, adult epilepsy, and schizophrenia. Further, the company has license and development agreements with Otsuka Pharmaceutical Co. Ltd.; Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
George Adam D.SecretaryNov 21Option Exercise0.0010,0001310,000Nov 23 04:30 PM